Capital Expenditure and Research and Development Spending Plan for the Next 3 Years
First written in FY2021. 15 of 16 entries say "Advanced", first in FY2022-Q2. Latest entry: FY2026.
4 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Group-wide research and development spending for the fiscal year totaled ¥158 billion.」
Research and development spending declined from ¥160 billion in the previous year to ¥158 billion, allocated to next-generation EyeSight, integrated control ECUs, and product development for BEVs, HEVs and ICE vehicles. Capital expenditures totaled ¥210.2 billion. - FY2026-H1AdvancedAnnual report
「Group-wide research and development spending for the six-month interim consolidated period totaled ¥74 billion, while research and development expenses recorded in the condensed interim consolidated income statement amounted to ¥76.7 billion. “Automotive 240,000” “Aerospace 8,000” “Other 2,000” “Total 250,000”」
Research and development spending totaled ¥74 billion for the interim period. In addition, the capital expenditure plan for the year, which had been undecided when the previous year's filing was submitted, was finalized at ¥240 billion for Automotive, ¥8 billion for Aerospace, ¥2 billion for Other, and ¥250 billion in total. - FY2025AdvancedAnnual report
「Group-wide research and development spending for the fiscal year totaled ¥160 billion.」
In connection with the previous plan to maintain annual research and development spending at around ¥120 billion for the next 3 years, research and development spending for the year totaled ¥160 billion. Capital expenditures totaled ¥176.1 billion. - FY2025-H1AdvancedAnnual report
「Group-wide research and development spending for the six-month interim consolidated period totaled ¥68.7 billion, while research and development expenses recorded in the condensed interim consolidated income statement amounted to ¥57.4 billion.」
In connection with the plan to maintain research and development spending at around ¥120 billion annually for the next 3 years, group-wide research and development spending for the first half totaled ¥68.7 billion. - FY2024AdvancedAnnual report
「Group-wide research and development spending for the fiscal year totaled ¥130.6 billion.」
In connection with the research and development spending plan for the next 3 years, research and development spending for the year totaled ¥130.6 billion, of which the Automotive business accounted for ¥129.6 billion. Capital expenditures totaled ¥167.5 billion. - FY2024-Q3AdvancedAnnual report
「During the nine months ended 31 December, group-wide research and development expenditures totaled ¥90.9 billion, while research and development expenses recorded in the condensed interim consolidated income statement totaled ¥81 billion.」
Against the plan to maintain research and development spending at around ¥120 billion annually for the next 3 years, group-wide research and development spending for the first 3 quarters totaled ¥90.9 billion. - FY2024-Q2AdvancedAnnual report
「During the six months ended 30 September, group-wide research and development expenditures totaled ¥62.1 billion, while research and development expenses recorded in the condensed interim consolidated income statement totaled ¥58.7 billion.」
Against the plan for research and development expenditures of approximately ¥120 billion per year over the next 3 years, group-wide research and development expenditures during the six months ended 30 September totaled ¥62.1 billion. - FY2024-Q1AdvancedAnnual report
「During the three months ended 30 June, group-wide research and development expenditures totaled ¥28 billion, while research and development expenses in the condensed interim consolidated income statement totaled ¥27.6 billion.」
Against the plan for research and development expenditures of approximately ¥120 billion per year over the next 3 years, group-wide research and development expenditures during the first quarter totaled ¥28 billion. - FY2023AdvancedAnnual report
「Group-wide research and development expenditures for the fiscal year totaled ¥107.8 billion.」
Against the plan for research and development expenditures of approximately ¥120 billion per year over the next 3 years, research and development expenditures for the fiscal year totaled ¥107.8 billion. Capital investment was ¥122.8 billion, and the plan for the following fiscal year was ¥180 billion. - FY2023-Q3AdvancedAnnual report
「During the nine months ended 31 December, research and development expenditures totaled ¥75.9 billion, while research and development expenses recorded in the condensed interim consolidated income statement totaled ¥79.7 billion.」
Against the plan for research and development expenditures of approximately ¥120 billion per year over the next 3 years, research and development expenditures for the nine-month period totaled ¥75.9 billion. - FY2023-Q2AdvancedAnnual report
「During the six months ended 30 September, group-wide research and development expenditures totaled ¥51.9 billion, while research and development expenses recorded in the condensed interim consolidated income statement totaled ¥54.1 billion.」
Against the plan for research and development expenditures of approximately ¥120 billion per year over the next 3 years, group-wide research and development expenditures during the first half totaled ¥51.9 billion. - FY2023-Q1AdvancedAnnual report
「During the three months ended 30 June, group-wide research and development expenditures totaled ¥23.1 billion, while research and development expenses in the condensed interim consolidated income statement totaled ¥25 billion.」
Against the plan for research and development expenditures of approximately ¥120 billion per year over the next 3 years, group-wide research and development expenditures during the first quarter totaled ¥23.1 billion. - FY2022AdvancedAnnual report
「Group-wide research and development expenditures for the fiscal year totaled ¥113.8 billion.」
Against the plan for research and development expenditures of approximately ¥120 billion per year over the next 3 years, group-wide research and development expenditures for the fiscal year totaled ¥113.8 billion. Capital investment was ¥86.1 billion, and the plan for the following fiscal year was ¥140 billion. - FY2022-Q3AdvancedAnnual report
「During the nine months ended 31 December, group-wide research and development expenditures totaled ¥86.9 billion, while research and development expenses recorded in the condensed interim consolidated income statement totaled ¥77.7 billion.」
Against the plan for research and development expenditures of approximately ¥120 billion per year over the next 3 years, group-wide research and development expenditures during the nine months ended 31 December totaled ¥86.9 billion. - FY2022-Q2AdvancedAnnual report
「During the six months ended 30 September, group-wide research and development expenditures totaled ¥61.6 billion, while research and development expenses recorded in the condensed interim consolidated income statement totaled ¥55.1 billion.」
Against the plan for research and development expenditures of approximately ¥120 billion per year over the next 3 years, group-wide research and development expenditures during the six months ended 30 September totaled ¥61.6 billion. - FY2021First statedAnnual report
「<Over the next 3 years> *Figures in parentheses are actual results for fiscal 2018–2020. Capital investment: 3.5–4.0% of revenue (3.5%); Research and development expenditures: approximately ¥120 billion per year (¥107.7 billion per year)」
For the next 3 years, the Company first presented a quantitative plan calling for capital investment of 3.5–4.0% of revenue and research and development expenditures of approximately ¥120 billion per year.